The excellent phase I/IIa clinical data of FG001 in aggressive brain cancer was presented at the World Molecular Imaging Congress
Copenhagen, Denmark, 3 October 2022 – FluoGuide A/S (“FluoGuide” or the “Company”) is pleased to inform of presentation of the outstanding clinical data from the completed phase I/IIa trial with FG001 in patients with aggressive brain cancer undergoing surgery, at the World Molecular Imaging Congress (WMIC) held 28 September – 1 October 2022 in Miami, US. Promising pre-clinical data on FG002 was also presented at the same conference.Andreas Kjaer, Professor and CSO at FluoGuide presented the excellent phase I/IIa clinical data of FG001 in aggressive brain cancer data at the World Molecular
In many of our Lesjöfors companies, we use apprenticeships as a strategic way to introduce, train and keep the most suitable staff for the future. In the UK, European Springs & Pressings has just on-boarded five new apprentices in an extensive program.The five apprentices have just joined the European Springs & Pressings family and begun the training that will launch them on their journey to becoming qualified engineers. Stuart McSheehy, MD of European Springs & Pressings explains why the company has chosen apprenticeships in their recruitment process:
“Apprentices and new workers are in
